Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orifarm AB
AB
Active
Org 5565487625
Klara Södra Kyrkogata 1, 111 52
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1997
12 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Orifarm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
568M
1B
2B
2B
1.4B
2020
2.0B
2021
1.7B
2022
1.4B
2023
2.0B
2024
EBITDA
SEK millions
0M
7M
14M
22M
29M
13M
2020
17M
2021
17M
2022
14M
2023
25M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 403 109
1 976 484
1 686 400
1 354 461
1 968 158
Staff expenses
—
—
—
—
—
EBITDA
12 682
16 906
16 864
13 544
24 602
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
12 682
16 906
16 864
13 544
24 602
Net financials
−3 981
−4 950
−4 076
2 501
34
Profit before tax
10 345
11 957
12 788
16 045
24 836
Tax
−2 214
−2 477
−2 551
−3 413
−5 578
Net profit
8 131
9 480
10 237
12 632
19 258
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
205 145
258 562
287 287
272 931
269 703
Equity
63 487
72 966
63 204
70 835
67 693
Long-term debt
0
0
0
0
0
Short-term debt
141 659
185 496
223 897
201 816
201 637
Total debt
141 659
185 496
223 897
201 816
201 637
Financial ratios
5-year trend
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
2020
2024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
2020
2024
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
2020
2024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
2020
2024
Asset turnover
7.30×
This company
1.12×
Market median
+552% vs market
2020
2024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Orifarm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
